A complete application in a minute
Tailored resume and cover letter, ready to send.
Caristo Diagnostics is hiring a Research Quantitative Imaging Scientist/ Platform Engineer at its Oxford headquarters. The role leads calibration capabilities for CT imaging and supports clinical service delivery, product innovation, and regulatory activities.
You will join a small, collaborative team bridging research, engineering, operations and clinical delivery to translate scientific ideas into deployable products while navigating changing priorities.
A fantastic opportunity has become available for a Quantitative Imaging Scientist to join Caristo Diagnostics rapidly growing team, based at our Oxford headquarters.
Caristo's technology depends on the accurate and reliable quantitative assessment of cardiac CT scans. This role owns the calibration capability that underpins both our current clinical services and the next generation of our AI-driven cardiovascular products.
You will join a small, highly collaborative Product Innovation team working at the interface between research, engineering, operations and clinical delivery. The role combines scientific thinking with practical execution and requires someone who can make good decisions despite incomplete information, competing priorities and changing requirements.
Success in this role is measured by keeping critical programmes moving, enabling clinical delivery, supporting product development and helping the company make pragmatic technical decisions. This is an ideal role for someone who enjoys solving real-world problems, working across teams and turning ambiguity into action.
Within 12 months you will:
We're looking for someone who:
With the first and only FDA approved (July 29, 2026) coronary artery inflammation diagnostic medical device, CaRi-Heart®, Caristo Diagnostics is a global leader in AI technologies for cardiovascular disease, founded as a spin‑out from the University of Oxford in 2018. Caristo also has an FDA approved (2025) coronary artery plaque diagnostic medical device. Its award‑winning inflammation technology helps detect hidden heart disease and identify people at risk of a heart attack before symptoms appear allowing for proactive disease management. Working with leading hospitals, research institutions, and pharmaceutical partners, Caristo aims to save lives through early detection and personalized prevention. The company was named a 2026 Technology Pioneer by the World Economic Forum in June 2026. Learn more at www.caristo.com or follow Caristo on LinkedIn, YouTube, and X.
Named first of "7 Technologies That Could Change Heart Healthcare Forevermore" by the Robb Report, the CaRi-Heart® technology is Caristo’s flagship offering which uncovers hidden coronary inflammation, a key driver of cardiovascular disease, on routine Coronary Computed Tomography Angiography (CCTA).
Research Quantitative Imaging Scientist/ Platform Engineer
Head of Research and Innovation
Oxford, UK (full time in-office)
Caristo Diagnostics is committed to diversity and inclusion, and encourages applications from all qualified candidates, including those making a step up in their career.
If you are passionate about making a difference in the world of medical imaging and meet the above criteria, we would love to hear from you.
Applicants should request Caristo’s Candidate Privacy Notice for information as to how we will handle your personal data.